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The new implantable hearing system Codacs™ was designed to close the treatment gap between active
middle ear implants and cochlear implants in cases of severe-to-profound mixed hearing loss. The
Codacs™ actuator is attached to conventional stapes prosthesis during the implantation and thereby
provides acoustical stimulation through a stapedotomy to the cochlea. Cochlear implants (CIs) on the
other hand are an established treatment option for profoundly deaf patients including mixed hearing
losses that are possible candidates for the Codacs™.
In this retrospective study, we compared the clinical outcome of 25 patients with the Codacs™ (3
month post-activation) to 54 CI patients (two years post-activation) with comparable pre-operative bone
conduction (BC) thresholds that were potential candidates for both categories of devices. The word
recognition score (Freiburg monosyllables test) in quiet was signiﬁcantly (p < 0.05) better in the
Codacs™ than in the corresponding CI patients for average pre-operative bone conduction below 60 dB
HL and equal in patients with a pre-operative BC PTA between 60 and 70 dB HL. Speech in noise
intelligibility (HSM sentences test at þ10 dB SNR) was signiﬁcantly (p < 0.001) better in Codacs™ (80%
median) than in CI patients (25% median) in all tested groups.
Our results indicate for patients with sufﬁcient cochlear reserve that speech intelligibility in noise with
the Codacs™ hearing implant is signiﬁcantly better than with a CI. Further, results in Codacs™ were
better predictable, encouraging the extension of the indication to patients with less cochlear reserve than
reported here.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The Direct Acoustic Cochlear Implant (DACI) stimulation device
Codacs™ (Cochlear Ltd.) was developed to close the treatment gap
between active middle ear implants with vibratory stimulation and
cochlea implants with electrical stimulation. Circumventing the
middle ear and stimulating the cochlea ﬂuids mechanically with an; CI, cochlear implant; DACI,
hulz-Moser test; MV, mean
n; SNR, signal to noise ratio;
ion score
, Department of Otorhinolar-
Carl-Neuberg-Str. 1, 30625
. Kludt).
B.V. This is an open access article uactuator driven conventional stapes piston through the stapes
footplate, it opens new possibilities for the treatment of patients
with severe-to-profound mixed hearing loss (Lenarz et al., 2013,
Lenarz, Schwab, Maier, Kludt, 2014, Lenarz, Verhaert et al., 2014).
In contrast to cochlea implants it relies on vibrational acoustic
stimulation and requires sufﬁcient residual hearing for a successful
treatment. By design the device has a possible maximum output
>120 dB SPL (Bernhard et al., 2011) and is able to cover the residual
dynamic range even in severe cases of hearing loss. Here the
question arises what the necessary residual hearing needed is for
successful treatment and how it can be determined. A multitude of
sophisticated standard audiological diagnostic instruments exist,
very few can be used in this patient group with mixed hearing loss,
often having AC thresholds beyond the audiometer limits. The
measurement of speech intelligibility could offer additional insight,
but is prevented by the pronounced air-bone gap and the technicalnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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only feasible method to estimate the “cochlear reserve” is bone
conduction (BC) pure-tone-audiometry. Although this method is
not able to cover the relevant thresholds range >90 dB HL
completely with available bone vibrators (e. g. B71) and distinction
between both ears may be difﬁcult, it provides a potential preop-
erative predictor for Codacs™ implantation outcomes.
Cochlear implants (CIs) are an established treatment option for
profoundly deaf patients including mixed hearing losses that are
now possible candidates for Codacs™. Steady technical improve-
ments have increased the speech intelligibility outcome after
cochlear implantation. In particular, electro-acoustical stimulation
has pushed the indication criteria for cochlear implantation to-
wards patients with signiﬁcant residual hearing.
Due to the overlapping indication criteria, some patients are
potential candidates for both treatment options. Our hypothesis in
the analysis here was that in patients with sufﬁcient residual
hearing speech intelligibility results especially in noise are better
when treated with acoustic stimulation than with electric or
electro-acoustic stimulation. Hence the aim of the present study
was to compare the outcome of patients with the Codacs™ to pa-
tients with a cochlear implant with a preoperative cochlear reserve
within the current Codacs™ indication criteria.
2. Patient demographics
The Codacs™ patient group presented here consisted of 25 pa-
tients. Fifteenwere implanted during two phases of the clinical trial
between 2009 and 2013 and 10 were implanted after the device
became commercially available in 2013. A new speech processor
(CP810, Cochlear Ltd., Australia) and new ﬁtting software (Cochlear
Codacs™ Fitting Software, Cochlear Ltd., Australia) was introduced
with themarket release of Codacs™. All Codacs™ patients analyzed
here were either directly ﬁtted or upgraded between two and four
years after the initial Codacs™ implantation to the CP810 with the
new ﬁtting software. The postoperative measurements of the
Codacs™ group presented in this study were performed three
months after the ﬁtting of the CP810 speech processor. Within the
investigated group six patients were already implantedwith a CI on
the contralateral side one to three years before the Codacs im-
plantations. The demographic data of this bimodal patient group is
presented in Table 1.
2.1. Codacs™ test group
The pre-operative BC pure tone average (PTA4; 0.5, 1, 2, 4 kHz) of
all Codacs™ patients was below 50 dB HL in four, between 50 and
60 dB HL in twelve and between 60 and 70 dB HL in nine cases.
Because the Codacs™ is indicated for severe-to-profound mixed
hearing loss most patients had an additional air-bone-gap  20 dB
HL that was not taken into account for the analysis here. The pre-
operative average BC was not altered by the implantation (see Re-
sults section for details). The average age at implantation of the
Codacs™was 63 ± 10 years (mean value (MV) ± standard deviationTable 1
Demographics of bimodal (Codacs/CI) patients.
Gender Previous surgeries Age at CI implantation [yrs.] Time between
1 Male e 46 1
2 Female e 58 1
3 Female stapedotomy both sides 66 3
4 Female stapedotomy Codacs side 52 2
5 Male e 43 1
6 Female tympanoplasty CI side 20 3(SD), min. 44, max. 80 years).
2.2. Cochlea implant reference group
For the CI reference group, patients implanted between 2005
and 2013 within the indication range, having a preoperative BC
equal or better 80 dB HL at 0.5, 1, 2 and 4 kHz were selected from
existing clinical ﬁles. The average preoperative BC PTA4 of these
patients was between 50 and 60 dB HL in 13, between 60 and 70 dB
HL in 26 and between 70 and 80 dB HL in 15 cases. The air con-
duction PTA4 of CI patients was worse than 70 dB HL due to a
pronounced air-bone gap. Due to air-bone gaps or rather pantonal
hearing losses, most patients were not considered for EAS stimu-
lation and were implanted with conventional CI electrodes. Even
though some patients had a sufﬁcient cochlear reserve at low fre-
quencies, the air-bone gap prevented effective use of an acoustic
component. Out of 13 patients with a Hybrid or Med El Flex who
could potentially use the acoustic component only 2 patients in the
CI reference group were actually using it. An overview of the de-
vices in the reference group is given in Table 2. CI patients older
than 80 years, non-native German speakers or those having addi-
tional cognitive disabilities were excluded from this study. The
average age at implantation in the CI reference group was 63 ± 11
years (MV ± SD, min. 33 yrs., max. 78 yrs.). No selection was made
regarding the manufacturer or cochlea implant type.
3. Methods
Pure tone BC thresholds were determined using a KHL 96 bone
conductor (CB-Elmec GmbH, Germany) on the mastoid. The tech-
nical limit of this device at 0.5, 1, 2 and 4 kHz was 60, 75, 80 and
70 dB HL at the respective frequencies. At frequencies where no
response could be obtained due to the limitations of the audiom-
eter (8 frequencies in 7 Codacs™ patients, pre- and postoperative
measurements), the threshold was approximated by a value 5 dB
HLworse than the audiometer limit at this frequency. BC thresholds
were measured one day before the implantation in all patients and
three month after ﬁtting with the CP810 speech processor for
Codacs™ patients. Preoperative BC thresholds in the CI reference
group as taken from clinical ﬁles were determined during the week
before the CI implantation.
Speech in quiet was assessed using the Freiburg monosyllable
test at 65 dB SPL and speech in noise was determined using the
Hochmair-Schulz-Moser (HSM) sentence test at þ10 dB SNR (65 dB
SPL speech level with 55 dB SPL noise level). All speech intelligi-
bility measurements were performed in sound ﬁeld with speech
and noise coming from the front (S0, S0N0) during routine visits at
our clinic three months (Codacs™) and two years (CI patients) post
activation. According to our experience, patients implanted with a
Codacs™ adapt very rapidly to the acoustic stimulation, whereas
speech intelligibility with CIs levels up to a plateau after two years
(Lenarz et al., 2011). To reﬂect the obtainable long term beneﬁt
these time points were chosen for the comparison.
To detect dependencies of the achieved results on preoperativeimplantation [yrs.] BC PTA4 CI side [dB HL] BC PTA4 Codacs side [dB HL]
BC not measureable; AC: 97.0 47.0
60.0 63.8
deaf (failed stapedotomy) 51.3
55.0 42.5
62.5 61.3
deaf (failed tympanoplasty) 52.5
Table 2
Overview of cochlea implant types in the CI reference group.
Manufacturer Cochlea implant type Number of implants
Advanced bionics (USA) HiRes90K 7
Med El (Austria) SONATA TI100 3
Concerto Flex EAS 4
Concerto Standard 3
Cochlear (Australia) Nucleus CI24RE Contour Advance 5
Nucleus Hybrid L24 9
Nucleus CI422 18
Nucleus CI512 5
Table 3
Number of Patients, preoperative average air-bone gap (ABG4, 0.5, 1, 2, 4 kHz) and
median speech intelligibility grouped by their preoperative BC PTA4.
BC PTA4 [dB HL] 41e50 51e60 61e70 71e80
Codacs Number of patients 4 12 9 e
ABG4 [dB HL] 34 30 24 e
WRS [%] 83 75 65 e
HSM [%] 87 87 78 e
CI Number of patients e 13 26 15
ABG4 [dB HL] e 19 7 4
WRS [%] e 60 63 60
HSM [%] e 21 21 33
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according to their preoperative BC pure tone average (PTA4; 0.5,1, 2,
4 kHz): (1a) better than 50 dB HL, (2a) worse than or equal to 50 dB
HL and less than 60 dB HL, (3a) worse than or equal to 60 dB HL
(Table 3). In the same manner CI patients were divided into three
groups according to their preoperative BC PTA4: (1b) better than
60 dB HL, (2b) worse than or equal to 60 dB HL and less than 70 dB
HL, (3b) worse than or equal to 70 dB HL. In the overlapping groups
(2a, 1b) and (3a, 2b) a statistical comparison of the outcome in
terms of intelligibility of speech in quiet and noise was performed.
Additionally, in bimodal patients implanted with a Codacs on
one and with a CI on the other side for which audiological results
for both devices was available (Table 1) a direct comparison of the
outcome in both groups was performed.90
1004. Results
When comparing preoperative BC pure-tone thresholds
(PTA4¼ 56.5 dB HL) to BC pure-tone thresholds at threemonth post
activation (PTA4 ¼ 54.1 dB HL) in Codacs™ patients, no statistically
detectable differences were found (p > 0.05, Shapiro-Wilk0.25 0.5 1 1.5 2 3 4 6 8
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Fig. 1. Change of BC PTA4 thresholds in Codacs™ patients between preoperative and
the evaluation 3 month after the CP810 ﬁtting. Negative values indicate an increase in
threshold (preoperative e postoperative). Individual results are depicted as thin grey
lines and the thick the line indicates the mean with the standard deviation (dashed).Normality Test, t- Student's t-test). Frequency speciﬁc BC thresh-
olds remained unchanged (Fig. 1) and no obvious decrease was
found at the second measurement 3 months after ﬁtting of the
CP810.4.1. Speech in quiet
The average speech intelligibility outcome of the Freiburg
monosyllables for the entire Codacs™ patient cohort was 72%
(mean, median ¼ 70%). The performance of these patients related
to their preoperative BC PTA4 is presented in Fig. 2. The Codacs™
patients showed a signiﬁcant performance decrease with increase
in BC (p < 0.02; Jonckheere-Terpstra-Test), indicating a correlation
with their cochlear reserve: Whereas the median Freiburg mono-
syllables word recognition score (WRS) was 83% in the group with
the smallest hearing loss (1a) it declined to 65% in the group with
most pronounced sensorineural hearing loss (3a). Nevertheless, all
Codacs™ patients achieved at least a 50% WRS in the Freiburg
monosyllabic test. In the CI patient cohort the average WRS in the
Freiburg monosyllable test was 60% (mean and median) with in-
dividual results varying between 20% and 95% WRS (Fig. 3). The
analysis of the CI patients in groups (1b) e (3b) according to their
preoperative BC threshold showed no signiﬁcant correlation be-
tween the cochlear reserve and speech intelligibility in quiet
(Jonckheere-Terpstra-Test).
Only the Codacs™ group (2a) was found signiﬁcantly (p < 0.03,
U-Test) better than the corresponding CI patient group (1b) in the
Freiburg monosyllabic test. The median in the Freiburg mono-
syllabic test for patients with preoperative BC PTA4 between 60 and40 45 50 55 60 65 70 75 80
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Fig. 2. Aided speech intelligibility in quiet determined with the Freiburg monosyllable
Test as a function of preoperative BC PTA4. Individual results are presented as small
symbols (B Codacs™, △ CI) and median of 10 dB HL interval groups (1a: 40e50 dB
HL; 2a, 1b: 50e60 dB HL; 3a, 2b: 60e70 dB HL; 3b: 70e80 dB HL) are indicated by large
symbols with the quartiles as dashed (CI) and dash-dotted lines (Codacs™).
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Fig. 3. Aided speech intelligibility in noise determined with the HSM test at þ10 dB
SNR as a function of preoperative BC PTA4. Individual results are presented as small
symbols (B Codacs™, △ CI) and median of 10 dB HL interval groups (1a: 40e50 dB
HL; 2a, 1b: 50e60 dB HL; 3a, 2b: 60e70 dB HL; 3b: 70e80 dB HL) are indicated by large
symbols with the quartiles as dashed (CI) and dash-dotted lines (Codacs™).
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vs. 63%). Nevertheless, the Codacs™ outcomes were much more
reliable. All Codacs™ patients achieve at least 50% WRS in quiet in
contrast to the CI results that were 15% WRS in some patients.
4.2. Speech in noise
The average score in the HSM sentence test at þ10 dB SNR was
76% mean (80% median) in the whole Codacs™ cohort. Comparison
of speech in noise performance in groups with different cochlear
reserve revealed 78% median score in the group with the worst
cochlear reserve (3a, BC PTA4 60 dB HL) compared to 87% median
in both other Codacs™ patient groups (Fig. 3). The minimum
speech in noise performance of all Codacs™ patient was 38%.
In contrast, the score of the entire CI patient cohort with 30%
mean WRS in the HSM sentence test showed a strong ﬂoor effect
and a considerably lower median of 25% (0% WRS in 14 out of 54
patients, Fig. 3). The analysis of the CI patients in groups (1b)e (3b),
according their preoperative BC threshold showed no signiﬁcant
correlation between the cochlear reserve and speech intelligibility
in noise (Jonckheere-Terpstra-Test).
Comparison of speech intelligibility in noise between Codacs™
and CI patients, revealed a highly signiﬁcant beneﬁt (both p< 0.001,
U-Test) for Codacs™ implanted patients in both overlapping groups
(2a/1b, 3a/2b) with BC PTA4 between 50 and 70 dB HL.
The individual speech intelligibility outcome of six bimodal
Codacs patients is presented in Fig. 4. The median performance of
these patients with the Codacs is higher both in quiet (57% with CI
and 82% with Codacs) and especially in noise (26% with CI and 88%
with Codacs).
5. Discussion
In this retrospective study we selected a cohort of CI patients
with severe to profound mixed hearing loss but sufﬁcient residual
hearing to be potential candidates for the Codacs™ to compare
results of electrical stimulation to acoustical stimulation in pa-
tients. As can be estimated from the distribution of our investigated
patient cohort here there is at least a substantial overlap for pa-
tients with a BC PTA4 between 50 and 70 dB HL that can be treated
either with a CI or the Codacs™. Whereas the implantation of a
Codacs™ does not restrict the later implantation of a CI, thedecision for a CI ﬁrst prohibits the later implantation of an acoustic
device and a strong need for evidence based decision criteria,
anticipating the outcome of acoustical and electrical stimulation in
patients is given.
The change in average BC thresholds after the surgery showed a
small, but statistical non-signiﬁcant trend for improvement. In
cases of otosclerosis the bone conduction improvement after
Codacs implantation may be due to the Carhart effect. On the other
hand individual changes (Fig. 1) showed a broad variability, which
may be attributed to the limited test e retest reliability of such
thresholds and the changed geometry by the posterior surgical
approach, although we could not detect changes in average BC
threshold due to the intervention.
In a ﬁrst step, the speech intelligibility in quiet determined with
the Freiburg monosyllable test in Codacs™ or CI implanted patients
was compared. According to our results, cochlea implanted patients
have sufﬁcient speech intelligibility in situations without back-
ground noise. Only Codacs™ patients with very good cochlear re-
serves (BC PTA4 < 60 dB HL) achieved signiﬁcantly better results in
quiet than patients from the corresponding CI group. Although the
2% difference in median outcome in the group with a BC PTA4
60e70 dB HL was clinically not relevant Codacs™ patients in this
group (3a) had much more reliable outcomes achieving minimally
55% WRS in contrast to CI results (2b) covering a broad range be-
tween 85% and 25% WRS. Also overall results, independently of the
preoperative BC threshold in the Freiburg monosyllable tests were
much more reliable in Codacs™ patients than in CI patients:
Codacs™ patients achieved at least a 50% WRS while results were
highly variable in CI patients and some went down to 20% WRS in
this task. Our obtained WRS in quiet is very close to Freiburg
monosyllable results in a study investigating the outcome of the
Nucleus CI24M (Cochlear Ltd.) on the better ear after 6 months
(Laszig et al., 2004). Lenarz et al (Lenarz et al., 2011). reported on
the performance of 511 CI patients implanted with a variety of
different devices between 2000 and 2008 (HiRes90K, Advanced
Bionics; Nucleus 24RE and Freedom, Cochlear Ltd.; C40 þ and
Pulsar, Med El). In this study an averageWRS of 62% in the Freiburg
monosyllables was found under the same conditions two years
after implantation which is in accordance to the speech intelligi-
bility of our CI reference group here. In a more recent study
(Seebens and Diller, 2012) that compares two different Med-El
devices, a similar WRS in quiet was found for the earlier model
(TEMPOþ) whereas the successor model (OPUS 2) showed a better
performance. Here the longer experience of CI patients may have
played a role.
Although the difference between the Codacs™ and CIs results in
quiet was not pronounced, the speech intelligibility in noise was
considerably better with the Codacs™ than in the corresponding CI
groups. Even the worst Codacs™ result of 38% WRS in the HSM
sentence test was better than the median CI patient in this task.
Overall median scores 25% vs. 80% were distinctively better in the
Codacs™ patients, reﬂected also by the highly signiﬁcant difference
between groups 2a/1b and 3a/2b. Analogue to the intelligibility in
quiet, results for hearing in noise were less variable and better
predictable in Codacs™ patients. While some CI patients achieved
scores above 80% in noise, this task remained completely impos-
sible (0% WRS) for about one fourth of CI patients even after two
years of training. The mean speech in noise score of 30%WRS in the
current CI cohort is considerably better than the 24% WRS in the
earlier mentioned study (Lenarz et al., 2011) in a large cohort with a
variety of different CIs two years after implantation for the HSM
sentence test atþ10 dB SNR. This difference can be explained by the
better precondition of our selected CI patient cohort. First, the
greater cohort included patients with profound long-term deafness
in contrast to our selected CI reference group that had a distinct
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Fig. 4. Comparison of (A) Freiburg monosyllables in quiet and (B) HSM sentence test in noise at þ10 dB SNR in bimodal patients.
E. Kludt et al. / Hearing Research 340 (2016) 185e190 189cochlear reserve. Second, some of CI patients that are presented in
the current study were implanted with the next generation of CIs
and some could proﬁt of electro acoustic stimulation (e.g. Hybrid-L
from Cochlear or Concerto Flex EAS from Med El), although only
two patients actually used this possibility. The speech processor
technology as well as coding strategies made advances that were
available for the later implanted CI patients. Our CI baseline in the
HSM test at þ10 dB SNR (65/55 dB SPL) is also in accordance with
earlier studies that found 22% WRS in a four-loudspeaker diagonal
conﬁguration (S45,225N135,315 (Schon et al., 2002). Another study
determined a meanWRS of 50% monaurally at þ10 dB SNR, but at a
higher level combination (70/60 dB SPL) 6 months after surgery
(Laszig et al., 2004). A more recent study, investigating the beneﬁt
of a processor upgrade from TEMPO þ to OPUS 2 (Med-El), found a
mean WRS of 35% for the older processor which is close to our
results. The same study indicated that an improvement to 52%WRS
is possible by the more elaborate processing of the current device.
In conclusion, the speech intelligibility results of the CI patients
selected as reference cohort for the Codacs™ patients werewithin a
reasonable range for the combination of devices and can be used for
estimation of electrical stimulation outcome. Even the results
found for the more recently introduced CI processor show that our
results obtained with the Codacs™ in a noisy situation were su-
perior to current cochlea implants.
The speech intelligibility outcome in patients implanted with CI
on one and Codacs™ on the other side conﬁrm this ﬁnding. Even
though some patients had worse preconditions on the CI implanted
side (e.g. due to failed previous surgeries) these patients still allow
a limited comparison within the same subject. Patients 2 and 3
showed no speech intelligibility difference between the CI and
Codacs™ side in quiet, but their speech intelligibility improved by
36% and 73% in noise. The four other patients improved both, in
quiet and noise. Hence, the results in bimodal patients support our
ﬁndings in separate CI and Codacs™ patients that the beneﬁts of
acoustic stimulation in noise predominate.
The advantage of acoustic stimulation crucially depends on the
residual cochlear reserve. The BC PTA4 thresholds showed stable
inner ear function in an interval up to four years in the ﬁrst
Codacs™ patients. However, the sensorineural hearing loss tends to
increase over time and could lead to performance reduction and
the need for a CI implantation eventually. Additional long term
studies of Codacs™ patients are needed to monitor BC thresholds
and the performance of the device to predict the possible time of
successful use and to provide evidence based indication criteria.In addition to audiological advantages in noisy environments,
our experience with the Codacs™ showed that the time and effort
for rehabilitation is signiﬁcantly reduced compared to cochlea
implants. Although not quantiﬁed here, patients adapted quickly to
the more natural acoustic stimuli and required signiﬁcant less
aftercare. To this promising ﬁndings may have contributed that
patients with acoustic stimulation probably have a comparable
frequency resolution to hearing aid patients with similar residual
hearing and a better presentation of temporal acoustic ﬁne struc-
ture in speech. Additionally, the Codacs™ better supports low fre-
quencies transmission than it is common in CIs and the usable
dynamic range can be assumed higher than in electric stimulation.
The more natural presentation of the acoustic input permitted a
fast and effortless adaptation to the direct acoustic stimulation and
possible factors contributing to this result needs to be investigated
in future studies.
Overall, the advantage of direct acoustical stimulation of the
inner ear over cochlear implantation is particularly noticeable in
difﬁcult hearing situations.
6. Conclusion
Our results indicate that for patients with sufﬁcient cochlear
reserve, speech intelligibility in noise with the Codacs™ hearing
implant is signiﬁcantly better thanwith a CI. In quiet, the advantage
of acoustical ampliﬁcation was signiﬁcant only for patients with
pre-operative BC above 60 dB PTA. Nevertheless, the performance
of the Codacs™ in quiet was 50% for all patients that were
implanted with Codacs™ up to date. Further, results in Codacs™
patients were more predictable, encouraging the extension of the
indication to less cochlear reserve than reported in the current
study.
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